Spain proposes new decree to improve access to medicines
This article was originally published in Scrip
New procedures for authorising off-label use, importing medicines unavailable in Spain and improving access to drugs still under clinical investigation are the key measures proposed in a new Royal Decree that should improve access to medicines in Spain.
You may also be interested in...
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.
Softening provisions to make EU-wide joint clinical assessments voluntary would make proposed legislation on HTA cooperation redundant, says Eurordis.